人类

TAFAZZIN - Tafazzin, Phospholipid-lysophospholipid Transacylase

Alias:
EFE
TAZ
BTHS
EFE2
G4.5
Taz1
CMD3A
LVNCX
Favorite
Basic Information
Sequence Homology
Related Diseases and Mutations
Transcripts & Proteins
Gene Expression
Interactions
Related Mouse Models
Related Drugs
References Literature
这个基因编码的蛋白质在心脏和骨骼肌中表达水平很高。这个基因的突变与许多临床病症有关,包括巴特综合征、扩张性心肌病(DCM)、肥厚性DCM、心内膜弹性纤维症和左心室非紧凑(LVNC)。已经描述了多种编码不同异型体的转录变异体。这些异型体的长形式和短形式都产生了;短形式缺乏疏水前导序列,可能作为细胞质蛋白存在而不是膜结合。已经描述了其他可选的剪接转录本,但所有这些转录本的全长度尚未可知。[由RefSeq,2008年7月提供]

Basic Information

NCBI
Transcripts
Exons
Length
MW (kDa)
Mutations
Related Diseases
Related Mouse Models
Reference
16
11
10188 bp
30.20
387
3
5
20

TAFAZZIN Genetics information (+)

GRCh38

Sequence Homology

Related Diseases and Mutations

#
Disease
Anatomical Category
Score
Mutations
No data available

Transcripts & Proteins

Table View
Tile View
#
Transcript
Length(nt)
Exon Count
CDS(bp)
Protein
Length(aa)
No data available
* This data comes from NCBI.

Gene Expression

Tissue-specific RNA expression

Organ
Abundance
Alphabetical

Cell-specific RNA expression

Organ
Abundance
Alphabetical

Interactions

Acting
Regulation
Detail
Mechanism
Target
Residues
Reference
Score
No data available

Related Mouse Models

Type
Name
MGI
Strain of Origin
Publications
Mutations
No data available

Related Drugs

Name
CAS Number
Status
Phase
Link
No data available

References Literature

Title
PMID
Journal
Year
IF
No Data Found!
Wechat
Mutation Direct
Sequence
Comparison
Al agent
Tutorials
Back to top